“AU5 tag標(biāo)簽抗體,Anti-AU5 tag抗體”應(yīng)用于IHC、WB、 IF、IP、ELISA，質(zhì)量保證，無(wú)效免費(fèi)退換，另外本公司生產(chǎn)經(jīng)營(yíng)各種標(biāo)記二抗、免疫印跡常用試劑、免疫組化常用試劑，咨詢(xún)！

產(chǎn)品介紹：

【產(chǎn)品名稱(chēng)】：AU5 tag標(biāo)簽抗體,Anti-AU5 tag抗體

【產(chǎn)品類(lèi)型】：一抗

【產(chǎn)品編號(hào)】：BYk-2113R                    

【相關(guān)標(biāo)記】: HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647

【性 狀】： Lyophilized or Liquid

【濃 度】： 1mg/1ml

【亞 型】： IgG

【規(guī) 格】：0.1ml/100ug，0.2ml/200ug

【抗體來(lái)源】： Rabbit OR MOUSE

【克隆類(lèi)型】： polyclonal or monoclonal

【產(chǎn)品用途】：科研實(shí)驗(yàn)，用于免疫組化實(shí)驗(yàn)，WB實(shí)驗(yàn)、IF、IP、ELISA實(shí)驗(yàn)，相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體，F(xiàn)ITC標(biāo)記，BIO等。

【貯 存】： Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

【詳細(xì)信息】： Core protein packages viral RNA to form a viral nucleocapsid, and promotes virion budding. Modulates viral translation initiation by interacting with HCV IRES and 40S ribosomal subunit. Also regulates many host cellular functions such as signaling pathways and apoptosis. Prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta （IFN-alpha/beta） and IFN-gamma signaling pathways and by inducing human STAT1 degradation. Plays an important role in virus-mediated cell transformation leading to hepatocellular carcinomas. Interacts with, and activates STAT3 leading to cellular transformation. May repress the promoter of p53, and sequester CREB3 and SP110 isoform3/Sp110b in the cytoplasm. Also represses cell cycle negative regulating factor CDKN1A, thereby interrupting an important check point of normal cell cycle regulation. Targets transcription factors involved in the regulation of inflammatory responses and in the immune response: suppresses NK-kappaB activation, and activates AP-1. Mediates apoptotic pathways throught association with TNF-type receptors TNFRSF1A and LTBR, although its effect on death receptors-induced apoptosis remains controvertial. Enhances TRAIL mediated apoptosis, suggesting that it might play a role in mediated apoptosis, suggesting that it might play a role in immune-mediated liver cell injury. Secreted core protein is able to bind C1QR1 at the T-cell surface, resulting in down-regulation of T-lymphocytes proliferation. May transactivate human MYC, Rous sarcoma virus LTR, and SV40 promoters. May suppress the human FOS and HIV-1 LTR activity. May alter lipid metabolism by interacting with hepatocellular proteins involved in lipid accumulation and storage.         

AU5 tag標(biāo)簽抗體,Anti-AU5 tag抗體【相關(guān)產(chǎn)品】：
 

Anti-KLC2抗體,驅(qū)動(dòng)蛋白輕鏈2抗體
Anti-KLC3抗體,驅(qū)動(dòng)蛋白輕鏈3抗體
Anti-KLC4抗體,驅(qū)動(dòng)蛋白輕鏈4抗體
Anti-KLF12抗體,鋅指轉(zhuǎn)錄抑制因子KLF12抗體
Anti-KLF15抗體,KLF15蛋白抗體
Anti-KLF16抗體,多巴胺受體調(diào)節(jié)因子DRRF抗體
Anti-KLHDC1抗體,KLHDC1蛋白抗體
Anti-KLHDC10抗體,KLHDC10蛋白抗體
Anti-KLHDC2抗體,肝癌相關(guān)抗原33抗體
Anti-KLHDC3抗體,KLHDC3蛋白抗體
Anti-KLHDC7B抗體,KLHDC7B蛋白抗體
Anti-KLHL1抗體,KLHL1蛋白抗體
Anti-KLHL15抗體,Kelch樣蛋白15抗體
Anti-KLHL18抗體,Kelch樣蛋白18抗體
Anti-KLHL2抗體,Kelch樣蛋白2抗體
Anti-KLHL29抗體,Kelch樣蛋白29抗體